Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
Abroad (travel likely)RecruitingPHASE2
Conditions
Pseudomyxoma Peritonei
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Contact: Study coordinator (Alessandra Raimondi, MD) · alessandra.raimondi@istitutotumori.mi.it · +39 02 2390 2581Contact: Study coordinator (Shigeki Kusamura, MD) · shigeki.kusamura@istitutotumori.mi.it · +39 02 2390 3441Contact: Principal Investigator (Alessandra Raimondi, MD)
Study leads
Alessandra Raimondi, MD
Principal Investigator
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano